Clobazam monotherapy for partial-onset or generalized-onset seizures

Cochrane Database of Systematic Reviews

Volumn 2014, Issue 10, 2014, Pages

  Arya, Ravindra ^a   Anand, Vidhu ^b   Garg, Sushil K ^b   Michael, Benedict D ^c,d  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF LIVERPOOL   (United Kingdom)

^d THE WALTON CENTRE NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAMAZEPINE; CLOBAZAM; PHENYTOIN; ANTICONVULSIVE AGENT; BENZODIAZEPINE DERIVATIVE;

CLINICAL EFFECTIVENESS; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DRUG TOLERANCE; EVIDENCE BASED PRACTICE; GENERALIZED ONSET SEIZURE; HUMAN; LONG TERM CARE; MONOTHERAPY; PARTIAL ONSET SEIZURE; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RETENTION TIME; REVIEW; RISK ASSESSMENT; SEIZURE; SYSTEMATIC REVIEW; TREATMENT DURATION; TREATMENT OUTCOME; ADOLESCENT; ADULT; CHILD; EPILEPSIES, PARTIAL; EPILEPSY, GENERALIZED; SEIZURES;

ADOLESCENT; ADULT; ANTICONVULSANTS; BENZODIAZEPINES; CARBAMAZEPINE; CHILD; EPILEPSIES, PARTIAL; EPILEPSY, GENERALIZED; HUMANS; PHENYTOIN; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SEIZURES;

EID: 84921973703     PISSN: 14651858     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD009258.pub2     Document Type: Review

References (38)

1. Canadian Study Group for Childhood Epilepsy. Clobazam has equivalent efficacy to carbamazepine and phenytoin as monotherapy for childhood epilepsy. Epilepsia 1998;39(9):952-9. [PUBMED: 9738674]
2. Kaushal S, Rani A, Chopra SC, Singh G. Safety and efficacy of clobazam versus phenytoin-sodium in the antiepileptic drug treatment of solitary cysticercus granulomas. Neurology India 2006;54(2):157-60. [PUBMED: 16804259]
3. Andrade R, García-Espinosa A, Machado-Rojas A, García-González ME, Trápaga-Quincoses O, Morales-Chacón LM. A prospective, open, controlled and randomised study of clobazam versus carbamazepine in patients with frequent episodes of Rolandic epilepsy [Estudio prospectivo, abierto, controlado y aleatorizado de clobazam frente a carbamacepina en pacientes con crisis frecuentes de epilepsia rolándica]. Revista de Neurologia 2009;49(11):581-6. [PUBMED: 19921623]
4. Bajaj AS, Bajaj BK, Puri V, Tayal G. Intermittent clobazam in febrile seizures: An Indian experience. Journal of Pediatric Neurology 2005;3(1):19-23.
5. Bawden HN, Camfield CS, Camfield PR, Cunningham C, Darwish H, Dooley JM, et al. The cognitive and behavioural effects of clobazam and standard monotherapy are comparable, Canadian Study Group for Childhood Epilepsy. Epilepsy Research 1999;33(2-3):133-43. [PUBMED: 10094425]
6. Feely M, Calvert R, Gibson J. Clobazam in catamenial epilepsy. A model for evaluating anticonvulsants. Lancet 1982;2(8289):71-3. [PUBMED: 6123810]
7. Feely M, Calvert R, Gibson J. Catamenial epilepsy as a model for testing a new anticonvulsant (clobazam). Irish Journal of Medical Science 1982;151(11):358-9.
8. Feely M, Calvert R, Gibson J. Clobazam in the treatment of catamenial epilepsy. British Journal of Clinical Pharmacology 1982;13(2):273P-4P. [: Abstract: Proceedings of the British Pharmacological Society; 1981 Sept 16-18; University of Oxford, Oxford, UK]
9. Feely M, Gibson J. Intermittent clobazam for catamenial epilepsy: tolerance avoided. Journal of Neurology, Neurosurgery, and Psychiatry 1984;47(12):1279-82. [PUBMED: 6392481]
10. Figueroa D, Adlerstein L, Manterola A. Clobazam in refractory epilepsies of children [Clobazam en epilepsias refractarias del nino]. Revista Chilena de Pediatria 1984;55(6):401-5. [PUBMED: 6399391]
11. Khosroshahi N, Faramarzi F, Salamati P, Haghighi SM, Kamrani K. Diazepam versus clobazam for intermittent prophylaxis of febrile seizures. Indian Journal of Pediatrics 2011;78(1):38-40. [PUBMED: 20890683]
12. Koeppen D, Baruzzi A, Capozza M, Chauvel P, Courjon J, Favel P, et al. Clobazam in therapy-resistant patients with partial epilepsy: a double-blind placebo-controlled crossover study. Epilepsia 1987;28(5):495-506. [PUBMED: 3115770]
13. Ramachandran Nair R, Parameswaran M, Girija AS. Intermittent oral prophylaxis in preventing recurrent febrile seizures, diazepam versus clobazam: a randomised study in south Indian rural children. Epilepsia 2005;46(Suppl 6):240.
14. Rose W, Kirubakaran C, Scott JX. Intermittent clobazam therapy in febrile seizures. Indian Journal of Pediatrics 2005;72(1):31-3. [PUBMED: 15684445]
15. Vajda FJ, Bladin PF, Parsons BJ. Clinical experience with clobazam: a new 1, 5 benzodiazepine in the treatment of refractory epilepsy. Clinical and Experimental Neurology 1985;21:177-82. [PUBMED: 3843217]
16. Yagi K, Takeda A, Kawai I. The clinical efficacy of nh-15 (clobazam) for the treatment refractory epilepsy by the double-blind comparative study with inactive placebo. Igakunoayumi 1995;174(3):229-41.
17. Yamatogi Y, Ohtahara S, Shigematsu H, Oguni H, Nakashima M. Single blind comparative study of clobazam (NH-15) with clonazepam in intractable childhood epilepsies. Journal of the Japan Epilepsy Society 1997;15(2):110-21.
18. Banerjee PN, Hauser WA. Incidence and Prevalence. In: Engel Jr J, Pedley TA editor(s). Epilepsy. A Comprehensive Textbook. 2nd Edition. Vol. 1, Philadelphia: Lippincott Williams & Wilkins, 2008:45-56.
19. Bucher HC, Guyatt GH, Griffith LE, Walter SD. The results of direct and indirect treatment comparisons in meta- analysis of randomised controlled trials. Journal of Clinical Epidemiology 1997;50(6):683-91.
20. Canadian Clobazam Cooperative Group. Clobazam in treatment of refractory epilepsy: the Canadian experience. A retrospective study. Epilepsia 1991;32(3):407-16.
21. Commission on Epidemiology and Prognosis, International League against Epilepsy. Guidelines for epidemiologic studies on epilepsy. Epilepsia 1993;34:592-6.
22. The ILAE Commission on Antiepileptic Drugs. Considerations on designing clinical trials to evaluate the place of new antiepileptic drugs in the treatment of newly diagnosed and chronic patients with epilepsy. Epilepsia 1998;39(7):799-803.
23. DerSimonian R, Laird N. Meta-analysis in clinical trials. Controlled Clinical Trials 1986;7(3):177-88.
24. Engel J Jr, Pedley TA. Introduction: What is Epilepsy?. In: Engel J Jr, Pedley TA editor(s). Epilepsy. A Comprehensive Textbook. 2nd Edition. Vol. 1, Philadelphia: Lippincott Williams & Wilkins, 2008:1-7.
25. Fisher RS, Van Emde Boas W, Blume W, Elger C, Genton P, Lee P, et al. Epileptic seizures and epilepsy. Definitions proposed by the International League against Epilepsy (ILAE) and the International Bureau for Epilepsy (IBE). Epilepsia 2005;46(4):470-2.
26. Glauser T, Ben-Menachem E, Bourgeois B, Cnaan A, Chadwick D, Guerreiro C, et al. ILAE Treatment Guidelines: Evidence-based analysis of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes. Epilepsia 2006;47(7):1094-120.
27. Glauser T, Ben-Menachem E, Bourgeois B, Cnaan A, Guerreiro C, Kalviainen R, et al.for the ILAE subcommission of AED Guidelines. Updated ILAE evidence review of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes. Epilepsia 2013;54(3):551-63. [PUBMED: 23350722]
28. Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003;327(7414):557-60.
29. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org. Cochrane Collaboration.
30. Lefebvre C, Manheimer E, Glanville J. Chapter 6: Searching for studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
31. Löscher W, Schmidt D. Diazepam increases aminobutyric acid in human cerebrospinal fluid. Journal of Neurochemistry 1987;49:152-7.
32. Macdonald R. Benzodiazepines. Mechanism of Action. In: Levy R, Mattson R, Meldrum B, et al. editor(s). Antiepileptic Drugs. 5th Edition. Philadelphia: Lippincott, Williams & Wilkins, 2002:179-86.
33. Murray CGL, Lopez AD. Global comparative assessment in the Health Sector, Disease Burden, Expenditures, and Intervention Packages. Geneva: WHO, 1994.
34. Porter RJ, Meldrum BS. Antiseizure Drugs. In: Katzung BG editor(s). Basic and Clinical Pharmacology. 10th Edition. Mc Graw Hill, 2007:374-94.
35. Rogawski MA, Löscher W. The neurobiology of antiepileptic drugs. Nature Reviews Neuroscience 2004;5(1):1-12.
36. Schmidt D, Rohde M, Wolf P, Roeder-Wanner U. Clobazam for refractory focal epilepsy. A controlled trial. Archives of Neurology 1986;43(8):824-6.
37. Schmidt D, Wilensky AJ. Benzodiazepines. In: Engel J Jr, Pedley TA editor(s). Epilepsy. A Comprehensive Textbook. 2nd Edition. Vol. 2, Philadelphia: Lippincott Williams & Wilkins, 2008:1531-41.
38. Schünemann HJ, Oxman AD, Vist GE, Higgins JPT, Deeks JJ, Glasziou P, et al. Chaper 12: Interpreting results and drawing conclusions. In Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated September 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.